$SBRA

Sabra Health Care REIT, Inc. (SBRA): Submission of Matters to a Vote of Security Holders

Sabra Health Care REIT, Inc. (SBRA) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. sbra-20260617 false 0001492298 0001492298 2026-06-17 2026-06-17 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported):

Original reporting
Published Jun 17, 2026, 8:40 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 17, 2026, 8:44 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$SBRA
Neutral
high confidence
Mentioned
$SBRA
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$SBRANeutralLow
01

Why it matters

Confirms election of seven directors, ratification of PricewaterhouseCoopers LLP as auditor for FY ending Dec. 31, 2026, and an advisory approval of named executive officer compensation.

02

Market read

Routine governance disclosure; no new financial metrics or corporate actions beyond vote tallies.

03

What to watch

Traders may instead focus on upcoming earnings, dividend/FFO updates, or any separate 8-K items (financing, acquisitions, guidance) not present here.

Relevance 6/10Novelty 2/10Timing: Filed June 17, 2026 after the annual meeting

Background

This SEC 8-K (Item 5.07) reports the final results of votes at Sabra Health Care REIT’s annual stockholders meeting held June 17, 2026.

Company-level read

Ticker impact

$SBRANeutralHigh confidence
Context

Sabra Health Care REIT reported final vote tallies from its June 17, 2026 annual meeting, including director elections and advisory compensation approval.

Expected impact

Likely limited near-term impact; any reaction would be more about sentiment around governance than fundamentals.

Evidence & confidence

Form 8-K Item 5.07 is a post-meeting disclosure of voting results; it does not introduce new strategy, earnings, or regulatory/financial developments.

Market effects

Minimal; governance vote outcomes are not sector-moving for healthcare REITs.

None indicated.

None indicated.

Counterpoint

Even routine say-on-pay results can matter if investors interpret vote margins as a signal of dissatisfaction, but this filing provides no narrative or change in policy.

Key entities

  • Sabra Health Care REIT, Inc.

    Subject of the filing; reported annual meeting voting results.

  • PricewaterhouseCoopers LLP

    Ratified as independent registered public accounting firm for FY ending Dec. 31, 2026.

  • Board of Directors nominees

    Seven individuals elected to serve until the 2027 annual meeting.

Related articles

$SBRAMed

Sabra Health Care REIT, Inc. (SBRA): Results of Operations and Financial Condition

Sabra Health Care REIT, Inc. (SBRA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE SABRA REPORTS SECOND QUARTER 2026 RESULTS; REITERATES 2026 GUIDANCE TUSTIN, CA, August 3, 2026 — Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the second quarter of 202

$SBRAMedAI 8/10

Why Sabra Health Care REIT Stock Soared Today

Sabra Health Care REIT (SBRA) shares rose over 10% after the company issued an operational update. Sabra said it signed letters of intent to retenant 26 Avamere properties, targeting $53M annual rent versus $41M prior. It also arranged to retire a $300M RCA mortgage with $200M cash. Sabra raised 2026 guidance to $0.37-$0.39 headline net income and $1.59-$1.61 normalized AFFO.

$BAHighAI 9/10

Air Force awards Boeing $131 billion ceiling contract for F-15 production, modernization

The U.S. Air Force awarded Boeing a $131.23 billion contract for F-15 production, modernization, and sustainment through 2037. The contract includes options for foreign military sales to several countries. Initial funding is $343,740 for fiscal 2026. Boeing will perform the work in St. Louis. The contract does not guarantee full spending and includes no immediate jet orders.

$AECMed

SW US: Anfield wants $50M for Utah mill

Anfield Energy (TSXV, Nasdaq: AEC) plans to raise $50M to refurbish Utah's Shootaring Canyon mill, aiming for a 2028 reopening. The mill will process uranium and vanadium, reducing U.S. reliance on imports. Capital expenditures are estimated at $80.1M, with flexibility in financing options. The company expects a mill licence by late 2024 or early 2027, unlocking financing and construction. An updated PEA forecasts significant after-tax NPV and IRR, with production from Velvet-Wood and Slick Rock